Cargando…

Nuclear Localization of BRAF(V600E) Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells

SIMPLE SUMMARY: Despite some successes of selective anti-BRAF(V600E) inhibitors, resistance remains a major challenge. The aim of our study is to determine the role of nuclear BRAF(V600E) and its newly identified partner, HMOX1, in melanoma aggressiveness and drug resistance. We identified the mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zerfaoui, Mourad, Toraih, Eman, Ruiz, Emmanuelle, Errami, Youssef, Attia, Abdallah S., Krzysztof, Moroz, Abd Elmageed, Zakaria Y., Kandil, Emad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773521/ https://www.ncbi.nlm.nih.gov/pubmed/35053476 http://dx.doi.org/10.3390/cancers14020311

Ejemplares similares

An Integrative Multi-Omics Analysis of The Molecular Links between Aging and Aggressiveness in Thyroid Cancers
por: Ruiz, Emmanuelle, et al.
Publicado: (2023)

A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma
por: Ruiz, Emmanuelle M., et al.
Publicado: (2023)

New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking
por: Zerfaoui, Mourad, et al.
Publicado: (2021)

Association of BRAF(V600E) Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies
por: Attia, Abdallah S., et al.
Publicado: (2022)

MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis
por: Toraih, Eman A., et al.
Publicado: (2021)

Targeting CDC7 sensitizes resistance melanoma cells to BRAF(V600E)-specific inhibitor by blocking the CDC7/MCM2-7 pathway
por: Gad, Shaimaa A., et al.
Publicado: (2019)

Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Thyroid Cancer Patients: A Systematic Review and Meta-Analysis
por: Toraih, Eman A., et al.
Publicado: (2021)

Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity
por: Makboul, Rania, et al.
Publicado: (2021)

Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease
por: Toraih, Eman A., et al.
Publicado: (2021)

A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence
por: Toraih, Eman A., et al.
Publicado: (2022)

Deciphering the Risk of Developing Second Primary Thyroid Cancer Following a Primary Malignancy—Who Is at the Greatest Risk?
por: Trinh, Lily N., et al.
Publicado: (2021)

Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study †
por: Kandil, Emad, et al.
Publicado: (2023)

Exosomes are the Driving Force in Preparing the Soil for the Metastatic Seeds: Lessons from the Prostate Cancer
por: Saber, Saber H., et al.
Publicado: (2020)

Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness
por: Zhang, Tao, et al.
Publicado: (2016)

Impact of BRAF(V600E) mutation on aggressiveness and outcomes in adult clonal histiocytosis
por: Razanamahery, Jerome, et al.
Publicado: (2023)

Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells
por: Lai, Xingrong, et al.
Publicado: (2022)

Upregulation of Endogenous HMOX1 Expression by a Computer-Designed Artificial Transcription Factor
por: Guo, Hongfeng, et al.
Publicado: (2010)

Hashimoto’s Thyroiditis: A Protective Factor against Recurrence in BRAF-Wild Type Differentiated Thyroid Carcinoma †
por: Issa, Peter P., et al.
Publicado: (2023)

BRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma
por: Tosuner, Zeynep, et al.
Publicado: (2018)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma
por: Hu, W, et al.
Publicado: (2013)

Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas
por: Issa, Peter P., et al.
Publicado: (2022)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer
por: Toraih, Eman A., et al.
Publicado: (2023)

A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer
por: Toraih, Eman A., et al.
Publicado: (2022)

Pan-Cancer Study on Variants of Canonical miRNA Biogenesis Pathway Components: A Pooled Analysis
por: Elshazli, Rami M., et al.
Publicado: (2023)

Cancer and COVID-19: analysis of patient outcomes
por: Aboueshia, Mohamed, et al.
Publicado: (2021)

BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival
por: Hugdahl, Emilia, et al.
Publicado: (2016)

Altered mental status is a predictor of poor outcomes in COVID-19 patients: A cohort study
por: Attia, Abdallah S., et al.
Publicado: (2021)

Donafenib and GSK‐J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression
por: Zheng, Chenyang, et al.
Publicado: (2023)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Acquired resistance to BRAF inhibition in BRAF(V600E) mutant gliomas
por: Yao, Tsun-Wen, et al.
Publicado: (2016)

Pseurotin A Validation as a Metastatic Castration-Resistant Prostate Cancer Recurrence-Suppressing Lead via PCSK9-LDLR Axis Modulation
por: Abdelwahed, Khaldoun S., et al.
Publicado: (2023)

Ultraviolet Light Exposure Decreases Thyroid Cancer Risk: A National Perspective
por: Lavorgna, Tessa R., et al.
Publicado: (2022)

Diagnostic Accuracy of Ultrasound in Predicting Extrathyroidal Extension and Its Relation to Body Mass Index in a North American Population
por: Omar, Mahmoud, et al.
Publicado: (2022)

HIGH FAT DIET INDUCES LUNG REMODELING IN APOE DEFICIENT MICE: AN ASSOCIATION WITH AN INCREASE IN CIRCULATORY AND LUNG INFLAMMATORY FACTORS
por: Naura, Amarjit S., et al.
Publicado: (2009)

Hmox1 Upregulation Is a Mutual Marker in Human Tumor Cells Exposed to Physical Plasma-Derived Oxidants
por: Bekeschus, Sander, et al.
Publicado: (2018)

Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
por: Ito, Takamichi, et al.
Publicado: (2020)

BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies
por: Zengarini, Corrado, et al.
Publicado: (2022)

Protective Effects of Garlic and Silymarin on NDEA-Induced Rats Hepatotoxicity
por: Shaarawy, Sabry M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1ck46pn78dggk6b3dfn7m8uitb